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Objective: MicroRNAs (miRNAs) have been implicated in regulating diverse cellular pathways and
involved in development and inﬂammation. This study aimed to examine six miRNAs expression during
the cartilage development and identify the key miRNA which is associated with chondrogenesis.
Methods: The expression of six miRNAs in cartilage tissue during development was screened by real-time
quantitative polymerase chain reaction (RT-qPCR). Rat models of bone matrix gelatin induced endo-
chondral ossiﬁcation, collagen-induced arthritis and pristane-induced arthritis were established to
examine whether miR-337 is involved in chondrogenesis. Furthermore, the regulation of transforming
growth factor-b type II receptor (TGFBR2) expression by miR-337 was determined with the luciferase
reporter gene assay and Western blot. The expression of some speciﬁc genes relevant to cartilage tissue
was tested by RT-qPCR after miR-337 mimic or inhibitor transfection.
Results: MiR-337 expression was signiﬁcantly down-regulated and almost disappeared in the maturation
phases of endochondral ossiﬁcation. The results of histology and RT-qPCR from three rat models showed
that miR-337 is directly bound up with chondrogenesis. Furthermore, the results from the luciferase
reporter gene assay and Western blot indicated that miR-337 regulated TGFBR2 expression. Our study
also found that the enhancement of miR-337 may modulate the expression of cartilage-speciﬁc genes
such as AGC1 in C-28/I2 chondrocytes.
Conclusion: We proved that miRNA-337 is associated with chondrogenesis through regulating TGFBR2
expression, and miRNA-337 can also inﬂuence cartilage-speciﬁc gene expression in chondrocytes. These
ﬁndings may provide an important clue for further research in the arthritis pathogenesis and suggest
a new remedy for arthritis treatment.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
MicroRNAs (miRNAs) constitute a large family of single-
stranded, small noncoding RNAs with the sequence length of
21e24 nucleotides and regulate deadenylation, translation, and
decay of their target mRNAs1,2. In human genome, miRNA genes are
conserved and themiRNA gene number is conservatively estimated
more than 20003. The transcripts of these miRNA genes can bindS. Lu, Department of Genetics
e of Medicine, Xi’an, Shaanxi
g), lushemin@mail.xjtu.edu.cn,
rk.
s Research Society International. Pwith the 30 untranslated region (30UTR) of their target mRNAs to
regulate gene functions. The functions of regulated genes involve
almost all aspects of cells, such as proliferation, differentiation,
motivation, communication, senescence and apoptosis. Recent
studies have been implicated in the pathogenesis of diseases,
especially in cancer development and progress4,5.
miRNAs, as key posttranscriptional regulators in a wide variety
of organisms, may regulate functions of up to 30% genes6. During
proliferation and differentiation of cartilage tissue, miRNAs also
play crucial regulative roles. For instance, miR-140 was ﬁrstly
reported to express speciﬁcally in the cartilage7, and then it was
validated to repress histone deacetylase 4 expression8. Recently,
miR-140 has been documented to regulate the expression of
insulin-like growth factor-binding protein 5 (IGFBP-5) and matrix
metallopeptidase 13 (MMP13) genes in human osteoarthriticublished by Elsevier Ltd. All rights reserved.
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genic differentiation of human adipose tissue-derived stem cells
through repressing the expression of SMAD1, a transcription factor10.
Recent studies have demonstrated that dysregulation of miRNAs
is also linked to osteochondral diseases. Mature miR-146a and
primary miR-146a/b are highly expressed in the synovial tissue of
rheumatoid arthritis (RA) patients11, and miR-146a could regulate
the expression of tumor necrosis factor receptor-associated factor 6
(TRAF6) and IL-1 receptor-associated kinase 1 (IRAK-1) which
participate in the pathogenesis of RA and osteoarthritis (OA)12.
In our previous study, we constructed three small RNA libraries
from the femoral head cartilage of SD rats at postnatal day 0, day 21
and day 42 and sequenced them by a deep sequencing approach.
We discovered 86 novel miRNA candidate genes and found that two
dozen miRNAs are up-regulated and half a dozen are down-
regulated during articular cartilage development. The predicted
targets of differentially expressed miRNAs include locally secreted
factors and transcription factors that may regulate proliferation and
differentiation of chondrocytes13. We also assume that these
miRNAs might play an important role in the pathogenesis of
osteochondral diseases through inﬂuencing the expression of
cartilage-speciﬁc genes. Based on our previous work and related
literature, we selected six miRNAs to determine their expression in
the cartilage tissue, and found that the expression of miR-337 was
signiﬁcantly down-regulated during the development. Next we
validated that miR-337 negatively regulated transforming growth
factor-b type II receptor (TGFBR2) protein by repressing the TGFBR2
transcripts. The results suggest that miR-337 acts as a repressor of
TGFBR2 expression to be involved in chondrogenesis.
Materials and methods
Rats
Sprague-Dawley (SD) rats purchased from the Animal Centre of
the Fourth Military Medical University, China and Dark Agouti (DA)
rats originated from the Section of Medical Inﬂammation Research,
Lund University, Sweden were bred and kept in a climate-
controlled environment, housed in polystyrene cages containing
wood shavings, and fed standard rodent chow and water ad libitum
in the SPF animal house of Department of Genetics and Molecular
Biology, Xi’an Jiaotong University College of Medicine. The experi-
ment had been approved by the Institutional Animal Ethics
Committee of the University.
Cartilage collection
Femoral head cartilage tissues were obtained from SD or DA rats
at postnatal day0 (D0), day 7 (D7), day 14 (D14), day21 (D21), day28
(D28), day 35 (D35) and day 42 (D42). In each time point,ﬁve female
and ﬁve male rats were included. The right femoral heads were
removed of the muscle and connective tissue to extract RNA as
previouslydescribed13. The other side femoral headswere sectioned
and stainedwith Safranin O after the routine histological treatment.Table I
The stem-loop RT primers of miR-cDNA
miRNAs Stem-loop RT pr
rno-miR-223 50-GTCGTATCCAG
rno-miR-377 50-GTCGTATCCAG
rno-miR-146a 50-GTCGTATCCAG
rno-miR-195 50-GTCGTATCCAG
rno-miR-337 50-GTCGTATCCAG
rno-Let-7a 50-GTCGTATCCAGRNA extraction and quantitation
RNA was extracted from the cartilage with TRIzol (Invitrogen,
Carlsbad, USA) according to the manufacturer’s instructions. For
quantifying the mature miRNAs, stem-loop real-time quantitative
polymerase chain reaction (RT-qPCR) was performed as previously
described14,15. miR-cDNAs were synthesized from total RNA by
utilizing Revertaid First Strand cDNA Synthesis kit according to
the manufacturer’s instructions (Fermentas, Canada). Brieﬂy, 2 mg
total RNA was added into a 20 ml reaction volume system which
contained stem-loop RT primer for mature miRNA and was incu-
bated at 70C for 5 min. And then 5 reaction buffer and
RiboLock inhibitor were added and incubated at 37C for 5 min.
After added Moloney Murine Leukemia Virus (MMLV) reverse
transcriptase, the mixture was incubated at 42C for 60 min. The
reaction was stopped by heating at 70C for 10 min and miR-cDNA
was stored at 20C. The stem-loop RT primer sequences of miR-
NAs are depicted in Table I.
For miRNA and mRNA quantitation, RT-qPCR was performed by
using iQ-5 (Bio-rad, CA, USA)with SYBR Premix Ex Taq II (TaKaRa,
Japan). In each assay, 1 ml cDNA (1:20 dilution) was used for ampli-
ﬁcation. The reactions were incubated in a 96-well optical plate at
95C for 5 min, then denaturing at 95C for 15 s, annealing and
polymerizing at 60C for 45 s. The relative gene expression normal-
ized by snRNA U6 and b-actin for miRNAs and mRNA, respectively,
was calculated with 2DDCT method. The information of primers,
products and annealing temperatures is depicted in Tables II and III.
Bone matrix gelatin induced endochondral ossiﬁcation (BMD-ECO)
Thebonematrix gelatin (BMG)wasprepared fromboneofDA rats
as previously described16. DA rats at age of 3 months were killed by
lethal dose of aether. Diaphyseal shafts of femur and tibia were
collected and dissected free of muscles. After exactly removed bone
marrow, bones were cut into chips about the size of 1 cm. Liquid
nitrogenwas used to freeze thebone shafts in this procedure to avoid
possible denaturation of proteins. After lipid of bones was removed
by chloroform/methanol (1/1), the bonewas demineralized in 0.6 M
HCL and BMG was extracted successively with the solution of 2.0 M
CaCl2, 0.5M ethylenediamine tetra acetic acid (EDTA), 0.8M LiCl and
water (55C) to remove soluble proteins. Then, the bone chips were
prepared by vacuum freeze-drying and stored in 20C.
Twenty DA rats received the syngeneic BMG implantation in
supraspinatus and rhomboid muscles. Each rat can be planted in six
pieces of BMG with the size of 1 cm. After 1, 2, 3, and 4 week of
implantation, the generated cartilaginous tissueswere harvested from
ﬁve rats of each time point, respectively. The partial tissue was sub-
jected to histological examination to observe the chondrogenesis and
the other was used for RT-qPCR to detect the expression of miR-337.
Induction of arthritis by collagen type II and pristane in rats
Twenty-seven DA rats at age of 8e12 weeks matched by sex and
age were randomly divided into three groups; collagen-inducedimers
TGCAGGGTCCGAGGTATTCGCACTGGATACGACTGGGGT
TGCAGGGTCCGAGGTATTCGCACTGGATACGACCCAAAA
TGCAGGGTCCGAGGTATTCGCACTGGATACGACAACCCA
TGCAGGGTCCGAGGTATTCGCACTGGATACGACCGGTTA
TGCAGGGTCCGAGGTATTCGCACTGGATACGACAAAGGC
TGCAGGGTCCGAGGTATTCGCACTGGATACGACAACTAT
Table II
The primers for detecting miRNA expression by quantitative RT-PCR
miRNAs Accession no. Forward primer
rno-miR-223 MIMAT0000892 50-CGCTGTCAGTTTGTCAAAT-30
rno-miR-377 MIMAT0003123 50-CGCAUCACACA AAGGCAAC-30
rno-miR-146a MIMAT0000852 50-CGCTGAGAACTGAATTCCA-30
rno-miR-195 MIMAT0000870 50-CGCTAGCAGCACAGAAATA-30
rno-miR-337 MIMAT0000577 50-CGCTTCAGCTCCTATATGA-30
rno-Let-7a MIMAT0000774 50-CGCTGAGGTAGTAGGTTGT-30
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(PIA) group 10 rats and control group seven rats. For CIA, CIA was
induced by a single intradermal injection of 150 ml emulsion con-
taining 150 mg rat collagen-II (CII) dissolved in 75 ml 0.1 mol/L acetic
acid and 75 ml incomplete Freund’s adjuvant (IFA) (SigmaeAldrich,
USA) at the base of the rat tail. Rat CII was puriﬁed from cartilage of
xiphoid process as previously described17. In the PIA model, rats
were subcutaneously injected with 150 ml pristane (Acros Organics,
Belgium) at the base of the tail. Control rats were subcutaneously
injected with 150 ml phosphate buffered saline (PBS). A macro-
scopic scoring system with the maximum score for each paw of 15
was used to monitor arthritis development in all four limbs. The
rats were observed three times per week after arthritis induction.
According to our previous ﬁnding that CIA predominantly inﬂu-
ences distal interphalangeal (DIP) joints, while PIA mainly inﬂu-
ences wrist/ankle joints and MCP/MTP joints during the disease
course, DIP joints and ankle joint taken from CIA rats and PIA rats
respectively were subjected to histological examination to observe
the pathological changes and to RT-qPCR to detect the expression of
miR-337.
Establishment of stably overexpressed miR-337 cell line
Pri-Has-miR-337 fragment was ampliﬁed by PCR used human
genome DNA as the template. The primers for PCR are forward
primer: 50 ATAAAGCTTGCCC AGGC 30 and reverse primer: 50
GGAATTCGGGCATAGTTC 30. The puriﬁed Pri-Has-miR-337 gene
fragment contains a seed sequence at the size of 509 bp. After
digested with HindIII and EcoRI (Takala, Japan), the gene fragment
was cloned into pcDNA3.1 vector (Invitrogen, Carlsbad, USA)
named Pri-337/pcDNA3.1. The sequencing analysis showed that the
gene fragment sequence was completely matched with the
sequence from GenBank (data not shown).
For obtaining stably overexpressed miR-337 cell line, human
embryonic kidney cell line HEK-293A was used to grow in Dul-
becco’s Modiﬁed Eagle’s Medium (DMEM)/low Glucose (GIBCO,
California, USA) with 10% heat-inactivated calf serum (Sijiqing,
China), and incubated at 37C in a humidiﬁed incubator with 5%
CO2. Brieﬂy, HEK-293A cells were seeded in six-well plates at
2  105 cells/well and transfected with Pri-337/pcDNA3.1 orTable III
The primers for detecting cartilage-speciﬁc genes of chondrocytes
Gene name Prime
AGC1 Forward primer: GGCATTTCAGCGGTTCCTTCTC
Reverse primer: AGCAGTTGTCTCCTCTTCTACGG
ADAMTS4 Forward primer: CGCACCGACCTCTTCAAG
Reverse primer: CTCCAGCACATAGTAGTAGCC
MMP3 Forward primer: AACAATGGACAAAGGATACAACAGG
Reverse primer: CATCTTGAGACAGGCGGAACC
MMP13 Forward primer: CAGTGGTGGTGATGAAGATGATTTG
Reverse primer: TCTAAGGTGTTATCGTCAAGTTTGC
b-Actin Forward primer: ATCGTGCGTGACATTAAGGAGAAG
Reverse primer: AGGAAGGAAGGCTGGAAGAGTGpcDNA3.1500 ng/well. The cells were allowed to attach for 12 h and
the mediumwas replaced with DMEM containing 1200 mg/ml G418
and 10% calf serum. This medium was changed every 3 days. Cells
acquiring G418 resistance developed into colonies, and individual
G418-resistant colonies were isolated. These cell lines were named
miR-337/pcDNA3.1-293A and pcDNA3.1-293A, respectively.
Bioinformatics and luciferase reporter assays
Among the approximately 100 targets predicted by the Tar-
getScan (http://www.targetscan.org/) search programs, TGFBR2
was of particular interest.
For luciferase reporter experiments, a 567bp segment of the
30UTR of the TGFBR2 gene was ampliﬁed by PCR from human cDNA
and inserted into the pMIR-report control vector (Ambion, ABI,
USA) by using the SacI and HindIII (Takala, Japan) site immediately
downstream from the stop codon of luciferase. The primer
sequences to generate TGFBR2 speciﬁc promoter fragment are:
forward primer: 5-CGAGCTCGGTGGAAGGTCTCATTTTATTG-3 and
reverse primer: 5-CCCAAGCTTGGGATGTAAAAGACAAACAATG-3.
The insert was conﬁrmed by sequencing (data not shown). HEK-
293A cells were seeded in 48-well plates at 2.4  104 cells/well and
co-transfected with 10 ng of the TGFBR2/pMIR-reporter and 50 nM
miR-337 mimic (or negative control) or 200 nM miR-337 inhibitor
(or negative control) (Genepharma, Shanghai, China) in each well
using Lipofectamine 2000 (Invitrogen, Carlsbad, USA).
The cell lines miR-337/pcDNA3.1-293A and pcDNA3.1-293A
were plated respectively in 48-well plates at 2.4  104 cells/well
and co-transfected with 180 ng of the TGFBR2/pMIR-reporter
plasmid and 20 ng pRL-TK plasmid (Promega, Beijing, China) in
each well by using Lipofectamine 2000 (Invitrogen, Carlsbad, USA).
Luciferase assays were performed 24 h after transfection by using
the Dual-Luciferase Reporter Assay System (Promega, Beijing,
China) on a GloMax Microplate Luminometer (Promega, USA).
Renilla luciferase activity was normalized to ﬁreﬂy luciferase
expression for each sample.
Transient transfection of miRNA mimic or anti-miR miRNA
inhibitors in chondrocytes
The human chondrocyte cell line, C-28/I2, was cultured in
DMEM, with 10% fetal calf serum (Sijiqing, China), in 5% CO2 at
37C. C-28/I2 cells were seeded in six-well plates at 2  105 cells/
well. After 24 h, 50 nM hsa-miR-337 mimic or negative control
(miR-neg) and 200 nM of anti-miR-337 (has-miR-337 inhibitor)
or control anti-miR (Genepharma, Shanghai, China) were tran-
siently transfected into C-28/I2 cells by Lipofectamine 2000.
Twenty-four hours after transfection, total RNA was isolated by
using TRIzol. cDNA was synthesized from 2 mg of total RNA by
utilizing a reverse transcription kit (Fermentas, Canada), in a ﬁnal
volume of 20 ml. The expression of cartilage-speciﬁc genesProduct size Annealing temperature
131 bp 61C
130 bp 59C
162 bp 61C
197 bp 64C
179 bp 61C
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using RT-qPCR.
Western blot analysis
Forty-eight hours after transfection with hsa-miR-337 mimic
or miR-neg and anti-miR-337 or control anti-miR, the chon-
drocytes were washed with PBS and then lysed over 20 min in
cold RIPA Lysis Buffer (Beyotime, Beijing, China). Extracts were
clariﬁed by centrifugation (12,000g) for 20 min at 4C. Protein
concentrations were determined by the bicinchonininc acid (BCA)
assay. Proteins were separated with 10% SDS-PAGE and trans-
ferred to a nitrocellulose membrane (Milipore, Massachusetts,
USA). The membrane was blocked in a solution of Tris-base
Solution (TBS) containing 5% nonfat dry milk and 0.05% Tween-20
(TBST-MILK) for 60 min at 25C with constant agitation, incu-
bated with rabbit anti-TGFBR polyclonal antibody (Beyotime,
Beijing, China) at dilution of 1:1000 for overnight at 4C, washed
with TBST, and incubated for 1 h with a goat anti-rabbit HRP-
conjugated IgG (Santa Cruz, Delaware, USA) at 1:5000 dilution.
After three additional washes, enhanced chemiluminescence
(ECL) was performed according to manufacturer’s protocol
(Pierce, Rockford, USA). The b-actin on the same membrane was
blotted with the antibody (Santa Cruz, Delaware, USA) as a
loading control. The experiment was performed at least in
triplicate.
Statistics assay
Data were expressed in 95% conﬁdence intervals and analyzed
by using Prism5 software. Statistical analysis was performed by
one-way analysis of variance (ANOVA) among groups, and then the
least signiﬁcant difference t test was employed to analyze the
signiﬁcant differences between groups. Bonferroni corrections
were applied to all multiple statistical tests. P value less than 0.05 is
considered as signiﬁcant.
Results
MiR-337 down-regulation during the cartilage development
The femoral heads from SD rats at postnatal day 0, 21 and 42
were stained with Safranin O staining to microscopically observe
the morphology of articular cartilage. The femoral heads at
postnatal day 0, 21 and 42 represent newborn/baby (0 y),
ablactation/child (5 y) and juvenile (11 y) of the human devel-
opmental stages respectively18 and manifested only cartilage
tissue without bone structure at postnatal day 0 [Fig. 1(A), D0],
the epiphyseal plate and the primary ossiﬁcation center at post-
natal day 21 [Fig. 1(A), D21], and the secondary ossiﬁcation center
and a mature articular structure at postnatal day 42 [Fig. 1(A),
D42], suggesting that cartilage cells differentiate normally during
the cartilage development.
The P-values of the tests for Gaussian distribution and
homogeneous variance were more than 0.05. The results of
stem-loop RT-qPCR showed that miR-146a and miR-195 were
up-regulated, and miR-337 was down-regulated during the
development process of articular cartilage; but miR-377 and
Let-7a did not show an obvious change [Fig. 1(B)]. Among these
miRNAs, we focused on miR-337, which showed the highest
expression, signiﬁcant change during the development and even
can hardly detect in the femoral head of adult rats. To conﬁrm
the result of our study, we detected the expression of miR-337
in seven development points of DA rats. We found that miR-
337 showed a more clearly downward trend (Fig. 2).miR-337 up-regulation in the chondrogenesis
To determine whether miRNA-337 is involved in chondro-
genesis during skeletal development, we used the BMG-ECO which
simulates the process of endochondral ossiﬁcation. The histological
results showed that the chondrocytes appeared in 1 week after
surgery, abundant chondrocyte mass was produced in 2e3 weeks,
and at the 4th week, chondrocytes were gradually decreased, and
replaced by blood vessels and bone tissue [Fig. 3(A)]. RT-qPCR
analyses showed that miR-337 expression reached the highest at
the 2nd or 3rd week and went down at the 4th week after the
induction consistent with the trend of chondrogenesis [Fig. 3(B)].
Different miR-337 expression in CIA and PIA
PIA and CIA rat models were commonly used for RA. Our
previous observation showed that PIA affects predominantly wrist/
ankle joints andmetacarpelphalangeal/metatarsophalangeal (MCP/
MTP) joints, whereas CIA mainly attacks DIP joints19. Therefore, we
chose ankle joints from PIA rats and DIP joints from CIA rats to
detect miR-337 expression. Histological results revealed that the
two models both showed joint deformation and swelling, however
DIP joints of CIA rats showed new cartilage and bone formation
[Fig. 4(A)], and ankle joints of PIA rats mainly manifested the
destruction of articular cartilage [Fig. (4C)], which is consistent
with our previous results19.
MiR-337 expression in cartilage of CIA rats was markedly higher
than that of control rats [Fig. 4(B)]. However, the expression of miR-
337 in the PIAmodel was too low to use RT-qPCR detection. Instead,
we used the semi-quantitative RT-PCR analysis to test the miR-337
expression [Fig. 4(E)], and the result showed that the expression of
miR-337 in PIA samples was signiﬁcantly lower than in control
samples [Fig. 4(D)]. These results showed that miR-337 expression
was directly related to the chondrogenesis.
Transcriptional regulation of TGFBR2 by miR-337
After analyzing the expression pattern of miR-337, we per-
formed computer-based predictions by using TargetScan softwares
to search for potential miR-337 targets associated with chondro-
genesis. Out of the 158 predicted targets (data not shown), TGFBR2
was selected for further study for its important role in chondro-
genesis. The sequence of miR-337 matched very well with the
sequence of 30UTR of TGFBR2 gene from human, rat and mouse
[Fig. 5(A)].
We cloned TGFBR2 downstream sequence into the luciferase
reporter gene and co-transfected with miR-337 and anti-miR-337.
The relative luciferase activity was reduced by 60% following co-
transfection with miR-337 mimic compared with transfection
with control RNA. By contrast, the transfection with miR-337
inhibitor increased to 51% of luciferase activity [Fig. 5(B)]. These
results suggested that miR-337 obviously targeted the 30UTR of
TGFBR2 gene.
We used the predicted target vector and Renilla luciferase
control vector toco-transfect HEK-293A, pcDNA3.1-293A and miR-
337/pcDNA3.1-293A cell lines. The results showed that the lucif-
erase activity was decreased in miR-337/pcDNA3.1-293A cells
compared with negative control pcDNA3.1-293A and HEK-293A
cells, and there was no difference between the pcDNA3.1-293A
and HEK-293A cells [Fig. 5(C)].
To determine whether overexpression of miR-337 could nega-
tively regulate TGFBR2 protein, C-28/I2 cells were transfected with
the mature miR-337 sequence (miR-337 mimic) or control miRNAs
(miR-neg). RT-qPCR results showed that miR-337 mimic increased
mature miR-337 levels by 100-fold compared with miR-neg [left
Fig. 2. Expression down-regulation of miR-337 during the cartilage development. (A) Agarose electropherogram of miR-337 expression in rat femoral heads at postnatal day
0 (D0), day 7 (D7), day 14 (D14), day 21 (D21), day 28 (D28), day 36 (D36) and day 42 (D42). Cartilage was collected from ﬁve female and ﬁve male DA rats for each development
stage. Stem-loop RT-PCR was performed by the pooled RNA from each time point sample and U6 was used as a reference. (B). MiR-337 expression detected by RT-qPCR in rat
femoral heads at postnatal day 0 (D0), day 7 (D7), day 14 (D14), day 21 (D21), day 28 (D28), day 36 (D36) and day 42 (D42). miR-337 relative expression was normalized to small
RNA U6. n ¼ 10 for each time point.
Fig. 1. Histology of left femoral head at different development stages and expression of six miRNAs in cartilage development. (A) Representative histological images of the left
femoral heads collected from rats at postnatal day 0 (D0), day 21 (D21) and day 42 (D42) and stained with Safranin O. (B) The expression levels of six miRNAs detected by RT-qPCR in
rat articular cartilage at postnatal day 0 (D0), day 21 (D21) and day 42 (D42). n ¼ 10 for each time point.
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Fig. 3. miR-337 up-regulation in endochondral ossiﬁcation model induced by bone morphogenetic gelatin. (A) Representative histological images of endochondral
ossiﬁcation model induced with bone morphogenetic gelatin at 1 (1W), 2 (2W), 3 (3W), and 4 (4W) weeks and stained with HE. (B) MiR-337 expression detected by RT-qPCR in
endochondral ossiﬁcation model induced with bone morphogenetic gelatin at 1 (1W), 2 (2W), 3 (3W), and 4 (4W) weeks. miR-337 relative expression was normalized to snRNA
U6. n ¼ 9 for each group.
Fig. 4. Different expression trends of miR-337 in rat cartilage of CIA and PIA. (A) Representative macroscopical and microscopical images of DIP joints of CIA rats. The arthritis
was induced in DA rats with homologus collagen type II and IFA. Macroscopical (upper panel) and microscopical (below panel) images were taken at day 26 after arthritis induction.
DIP joints from control (left panel) and arthritic rats (right panel) were sectioned and stained with HE. (B) MiR-337 expression detected by RT-qPCR in rat DIP joint cartilage of CIA.
(C) Representative macroscopical and microscopical images of ankle joints of PIA rats. The arthritis was induced in DA rats with pristane. Macroscopical (upper panel) and
microscopical (below panel) images were taken at day 26 after arthritis induction. Ankle joints from control (left panel) and arthritic rats (right panel) were sectioned and stained
with HE. (D) Agarose electropherogram of miR-337 expression in rat ankle joints of PIA. (E) MiR-337 expression in rat ankle joints of PIA by semi-quantitative RT-PCR. U6 was used
as reference. n ¼ 10 for each arthritis group and n ¼ 7 for control group.
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transfected the miR-337 mimic for 24 h or 48 h, miR-337 cannot
inﬂuence the mRNA expression of TGFBR2 [right panel of Fig. 5(D)],
and the inhibitor of miR-337 also cannot affect the mRNA [right
panel of Fig. 5(E)]. These results demonstrated that miR-337 hardly
affects the mRNA stability and degradation. Furthermore, we veri-
ﬁed whether transfection with miR-337 mimic or inhibitor could
affect TGFBR2 protein expression. We found that miR-337 mimic
signiﬁcantly decreased the TGFBR2 protein expression compared
with negative control [Fig. 5(F)]. These data suggested that miR-337
actually acted as a repressor to regulate TGFBR2 protein in C-28/I2
cells. However it is very difﬁcult to increase the TGFBR2 protein
when we treated the cells with miR-337 inhibitor [Fig. 5(G)]. We
repeated this experiment at least three times and obtained the
same results.
Cartilage-speciﬁc gene expression in response to stimulation of miR-
337 mimic and inhibitor in C-28/I2 cells
To further determine the role of miR-337 in chondrocytes, we
investigated whether miR-337 could affect the expression of
cartilage-speciﬁc genes. After transfected C-28/I2 cells with miR-
337 mimic, inhibitor and miR-neg for 24 h, we detected mRNA
expression of AGC1, MMP3, MMP13 and ADAMTS4 by RT-qPCR.
AGC1 and ADAMTS4 transcripts in chondrocytes were signiﬁ-
cantly increased after treatment with miR-337 mimic, while MMP3
mRNA expression was markedly decreased and MMP13 did not
obviously change [Fig. 6(A)]. Moreover, miR-337 inhibitor only
inﬂuenced AGC1 and did not make the other gene expression
changed.
Discussion
In this study we revealed that miR-337 was very low and even
hardly detected in the femoral head of adult rats, but highly
expressed during the cartilage proliferation. Previous miRNA
microarray data supported that a series of miRNAs could promote
cartilage formation andmiR-337 is always in the results20e23. Sowe
surmised that miR-337 was involved in chondrogenesis. Firstly, we
used BMG-ECO, a classical endochondral ossiﬁcation model, to
examine miR-337 expression in the different endochondral ossiﬁ-
cation stage. The results showed that the expression of miR-337
was gradually increased with the formation of the cartilage and
dropped off with bone formation. Secondly, we used PIA and CIA
models to observe miR-337 expression. The expression of miR-337
in the two models was diametrically opposed: miR-337 was highly
expressed in CIA model but it was very low in PIA model. Although
the both diseases manifest similar macroscopic changes such as
redness and swelling in the affected joints, CIA is mainly affected
DIP joints and has obvious new cartilage formation, while PIA
frequently affects ankle/wrist joints and has severe cartilage
destruction. From a previous study of articular cartilage miRNA
proﬁle from OA patents, 365 miRNAs have been identiﬁed to
participate in pathogenesis of the arthritis; and among these
miRNAs, miR-337 is obviously down-regulated in osteoarthritic
cartilage compared to normal cartilage24. In both experimental
arthritis and human diseases we can conclude that if the cartilage
tissue is destructed, miR-337 expression will decrease, while its
expression increases when there is a new cartilage formation,
indicating that miR-337 expression is associated with the
chondrogenesis.
To understand the mechanisms how miR-337 induces chon-
drogenesis, we used computational methods to help identify the
targets of miR-337 in mice, rats and humans. Among the approxi-
mately 100 targets predicted by the TargetScan search program, wefocused on the gene of TGFBR2 which was well known for its
important roles in cartilage development and inﬂammation. We
used the dual-luciferase reporter system to explore the relationship
between miR-337 and TGFBR2. Our results showed that the miR-
337 was a repressor for TGFBR2. We analyzed the protein level of
TGFBR2 byWestern blot after transfecting C-28/I2 cells with mimic
or inhibitor of miR-337. The results showed that the mimic (or
inhibitor) did not affect the mRNA expression of TGFBR2 but the
mimic of miR-337 signiﬁcantly down-regulated the accumulation
of TGFBR2 protein, conﬁrming that it is indeed a target of miR-337.
However, when we used the inhibitor of miR-337 to suppress the
expression of miR-337, there was no obvious increase of TGFBR2
protein. We surmise that the expression of miR-337 on the mature
cartilage cell line C-28/I2 is not very high, and the level of TGFBR2 is
higher, so it is easy to increase the miR-337 while difﬁcult to
decrease it.
Transforming growth factor-b (TGF-b) signaling pathway plays
important roles in regulating cell proliferation, differentiation,
migration and apoptosis in a broad spectrum of tissues25. TGF-
b abundantly expresses in bone tissues and has dramatic effects on
the bone cells responsible for bone formation and resorption26,27.
TGFBR2 also is required for normal development of the skeleton
and that TGFBR2 can negativelymediate chondrogenesis28. The loss
of TGFBR2 also results in defects in the development of the skull
vault, indicating that TGFBR2 has a critical role in intramembranous
bone formation as well as endochondral bone formation29. Over-
expressing a dominant negative TGF-b receptor results in
a terminal chondrocyte differentiation30. Our ﬁndings provided the
evidence that when chondrocytes are differentiating, the expres-
sion of miR-337 is gradually decreased, so its target gene TGFBR2 is
gradually escaped its inhibitory effect.
After chondrocytes were transfected the mimic of miR-337, the
mRNA expression of AGC1 was signiﬁcantly up-regulated. At the
contrast, when the inhibitor of miR-337 was transfected into the
cells, AGC1 expression was reduced. These results suggested that
the augment of miR-337 activity can promote the ability to
anabolism of cartilaginous tissues. On the other side, catabolism of
the cartilage showed an opposite trend under the inﬂuence of
miR-337. It has been reported that the MMP3 activity was greatly
increased in degraded cartilage of OA patients31. Our experiment
showed that miR-337 can inhibit the activity of the MMP3 to
prevent cartilage degradation. However, we could not observe the
effect when the cells were transfected with miR-337 inhibitor,
which is likely that miR-337 expression is very low in the mature
cartilage cell line C-28/I2, so the miR-337 inhibitor is very difﬁcult
to play an effective role.
These data point to a hitherto unrecognized role of miR-337
with the low expression in the destructed articular cartilage,
and prove that miR-337 can regulate TGFBR2 expression. We also
demonstrate that miR-337 is associated with chondrogenesis. The
ﬁndings may provide a vital clue for further research in the
arthritis pathogenesis and suggest a new target for arthritis
treatment.
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